Procept Biorobotics
PRCT
145 hedge funds and large institutions have $1.92B invested in Procept Biorobotics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 67 increasing their positions, 38 reducing their positions, and 12 closing their positions.
239% more call options, than puts
Call options by funds: $36.2M | Put options by funds: $10.7M
158% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 12
76% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 38
32% more capital invested
Capital invested by funds: $1.46B → $1.92B (+$461M)
14% more funds holding
Funds holding: 127 → 145 (+18)
1.24% more ownership
Funds ownership: 89.52% → 90.75% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AllianceBernstein
Nashville,
Tennessee
|
+$49.7M |
| 2 |
BlackRock
New York
|
+$14.1M |
| 3 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$12.6M |
| 4 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
+$11.5M |
| 5 |
Morgan Stanley
New York
|
+$11.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$29.2M |
| 2 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$25.9M |
| 3 |
B
Braidwell
Stamford,
Connecticut
|
-$10.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.54M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.53M |
PRCT Hedge Fund Activity: Q4 2023 in Review
145 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2023, worth a combined $1.92B — up 32% from $1.46B a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new PRCT positions and 12 closed out — a net gain of 19 holders — while 67 added to existing stakes and 38 trimmed.
The largest buyer was AllianceBernstein, adding an estimated $49.7M. The largest seller was Citadel Advisors, cutting an estimated $29.2M.
- 145 institutional investors held Procept Biorobotics (PRCT) as of Q4 2023, up from 127 in Q3 2023.
- Funds reported $1.92B of Procept Biorobotics stock for Q4 2023, up 32% quarter-over-quarter.
- 31 funds opened new Procept Biorobotics positions in Q4 2023 and 12 closed out, a net change of +19 holders.
- The largest Procept Biorobotics buyer in Q4 2023 was AllianceBernstein, an estimated $49.7M added.
- The largest Procept Biorobotics seller in Q4 2023 was Citadel Advisors, an estimated $29.2M sold.
Based on aggregated 13F filings for Q4 2023.